Barclays’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-104,332
Closed -$8.33M 4304
2021
Q1
$8.33M Buy
104,332
+85,938
+467% +$6.86M ﹤0.01% 898
2020
Q4
$1.45M Sell
18,394
-21,313
-54% -$1.68M ﹤0.01% 1770
2020
Q3
$1.75M Sell
39,707
-34,446
-46% -$1.51M ﹤0.01% 1583
2020
Q2
$3.28M Sell
74,153
-29,575
-29% -$1.31M ﹤0.01% 1161
2020
Q1
$3.72M Buy
103,728
+48,506
+88% +$1.74M ﹤0.01% 1012
2019
Q4
$3.92M Buy
55,222
+15,990
+41% +$1.13M ﹤0.01% 1410
2019
Q3
$2.93M Buy
39,232
+14,541
+59% +$1.09M ﹤0.01% 1452
2019
Q2
$1.99M Buy
24,691
+18,406
+293% +$1.48M ﹤0.01% 1816
2019
Q1
$421K Sell
6,285
-14,141
-69% -$947K ﹤0.01% 2706
2018
Q4
$1.52M Sell
20,426
-1,751
-8% -$130K ﹤0.01% 1530
2018
Q3
$2.04M Sell
22,177
-32,755
-60% -$3.02M ﹤0.01% 1764
2018
Q2
$5.4M Buy
54,932
+45,752
+498% +$4.5M ﹤0.01% 954
2018
Q1
$1.02M Buy
9,180
+1,893
+26% +$211K ﹤0.01% 1798
2017
Q4
$749K Buy
7,287
+3,247
+80% +$334K ﹤0.01% 1809
2017
Q3
$381K Sell
4,040
-274
-6% -$25.8K ﹤0.01% 2069
2017
Q2
$336K Buy
4,314
+3,593
+498% +$280K ﹤0.01% 2132
2017
Q1
$57K Sell
721
-479
-40% -$37.9K ﹤0.01% 3058
2016
Q4
$94K Sell
1,200
-1,082
-47% -$84.8K ﹤0.01% 2633
2016
Q3
$178K Sell
2,282
-5,509
-71% -$430K ﹤0.01% 2180
2016
Q2
$535K Buy
+7,791
New +$535K ﹤0.01% 1730
2016
Q1
Sell
-290
Closed -$18K 3774
2015
Q4
$18K Sell
290
-39
-12% -$2.42K ﹤0.01% 2720
2015
Q3
$18K Sell
329
-12,989
-98% -$711K ﹤0.01% 2879
2015
Q2
$706K Buy
13,318
+10,320
+344% +$547K ﹤0.01% 1630
2015
Q1
$141K Sell
2,998
-1,879
-39% -$88.4K ﹤0.01% 2386
2014
Q4
$209K Buy
4,877
+3,314
+212% +$142K ﹤0.01% 2353
2014
Q3
$53K Buy
1,563
+957
+158% +$32.5K ﹤0.01% 2974
2014
Q2
$22K Sell
606
-779
-56% -$28.3K ﹤0.01% 3378
2014
Q1
$45K Sell
1,385
-13,299
-91% -$432K ﹤0.01% 3222
2013
Q4
$485K Sell
14,684
-5,836
-28% -$193K ﹤0.01% 2161
2013
Q3
$636K Sell
20,520
-4,233
-17% -$131K ﹤0.01% 1978
2013
Q2
$559K Buy
+24,753
New +$559K ﹤0.01% 2135